Target intelligence / Profile preview

Arrestin-C (ARR3)

Target
ARR3
Molecular classification
Other
01

Overview

Arrestin-C (ARR3), also referred to as cone arrestin or X-arrestin, is a member of the arrestin protein family predominantly expressed in cone photoreceptor cells of the vertebrate retina[1][5]. Its primary function is to regulate signal transduction initiated by activation of G protein-coupled receptors (GPCRs) such as cone opsins, facilitating receptor desensitization, endocytosis, and the proper shutoff of visual signaling[1][2][4][5]. Arrestin-C binds activated, phosphorylated forms of cone opsins and plays a key role in returning photoreceptor cells to their baseline state after light exposure[1]. Although crucial for cone cell biology and visual function, Arrestin-C is not currently considered a therapeutic drug target nor is it recognized as a disease biomarker; its dysfunction has not been definitively linked to a major human disease or directly targeted by medicines[1][5]. Arrestin-C is structurally distinct from the non-visual arrestins (arrestin-2/β-arrestin and arrestin-3), which modulate a broader range of GPCR signaling outside the retina[1]. **Notes/Explanation for is_incorrect:** ARR3 is a specific protein but is not considered a classic "therapeutic target" such as a receptor, enzyme, transporter, or ion channel. It is not a canonical receptor or membrane signaling protein but rather an intracellular regulator, mainly in photoreceptor cells. No drugs are known to interact with this protein, and it is not established as a drug target in therapeutic pipelines or clinical trials. Some of the submitted aliases overlap with other arrestins (such as arrestin-3, which refers elsewhere to β-arrestin 2), but ARR3/Arrestin-C specifically denotes cone arrestin, not β-arrestin subtypes[4][5]. Because of overlap with other arrestins and potential confusion with β-arrestin 2 (which *is* sometimes called arrestin-3 in literature but is not ARR3), this entry must be handled with caution, and it is currently **not a validated therapeutic target**.

Other names
ARR3Arrestin-CARRXCARC-arrestincArrCone arrestinRetinal cone arrestin-3X-arrestinarrestin 4cone arrestinMYP26arrestin 3 retinal (X-arrestin)retinal cone arrestin-3
02

Biological functions

Signal transductionRegulation of G protein-coupled receptor (GPCR) signalingOpsin (photopigment) bindingGPCR trafficking and endocytosis
03

Disease associations

Other (no consistent or established role as a direct therapeutic target; contextually associated with retinal/cellular signaling disorders, but not recognized as a canonical disease target)

Beyond the preview

Go deeper on Arrestin-C (ARR3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arrestin-C (ARR3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call